Airlift Bioreactors Market Report 2026

Airlift Bioreactors Market Overview

• Airlift Bioreactors market size has reached to $4.32 billion in 2025 • Expected to grow to $6.71 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Rising Demand For Biopharmaceutical Products In Cell Culture Protein Surface Coating Market • Market Trend: Advancements In Cloud-Integrated Airlift Bioreactors Enhance Process Efficiency And Automation In Bioprocessing • North America was the largest region in 2025.

What Is Covered Under Airlift Bioreactors Market?

Airlift bioreactors are tower reactors designed for large-scale aerobic cultures, where the mixing of the culture broth is achieved using an airlift pump that introduces gas into the system. Airlift bioreactors are used to cultivate microorganisms, plant, and animal cells, especially in pharmaceutical, enzyme, and biofuel production. The main products of airlift bioreactors are internal airlift loop bioreactors and external airlift loop bioreactors. An internal airlift loop bioreactor has a single vessel divided into two interconnected zones, the riser and the downcomer, where the liquid flows back down. The various capacities include 5 liters, 7 liters, 10 liters, and 30 liters for different usages, such as single-use or disposal, and reusable. The variety of production scales includes laboratory scale, pilot scale, and large scale for different end-users, including biopharmaceutical companies, contract research organizations (CRS) or contract development and manufacturing organizations (CDMOs), and research and development companies.

What Is The Airlift Bioreactors Market Growth Forecast?

The airlift bioreactors market size is expected to see strong growth in the next few years. It will grow to $6.71 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing demand for biologics and vaccines, rising investments in sustainable bio-manufacturing, expansion of contract manufacturing services, growing focus on process intensification, increasing adoption of smart bioreactor control systems. Major trends in the forecast period include increasing adoption of single-use airlift bioreactor systems, rising demand for large-scale aerobic fermentation solutions, growing integration of advanced process monitoring sensors, expansion of modular and scalable bioreactor designs, enhanced focus on energy-efficient mixing mechanisms.

Tariff Impact On Airlift Bioreactors Market

Tariffs are impacting the airlift bioreactors market by increasing costs of imported stainless steel vessels, precision sensors, control systems, and specialized fabrication components used in laboratory, pilot, and large-scale reactors. Biopharmaceutical and biotechnology hubs in North America and Europe are most affected due to reliance on imported high-grade materials, while Asia-Pacific faces cost pressure on export-oriented equipment manufacturing. These tariffs are raising capital expenditure and extending procurement timelines. However, they are also encouraging localized equipment fabrication, regional supplier development, and innovation in cost-efficient and modular airlift bioreactor designs.

Global Airlift Bioreactors Market Segmentation

1) By Product: Internal Airlift Loop Bioreactor, External Airlift Loop Bioreactor 2) By Capacity: 5 Liters, 7 Liters, 10 Liters, 30 Liters 3) By Usage: Single-Use Or Disposal, Reusable 4) By Production Scale: Laboratory Scale, Pilot-Scale, Large Scale 5) By End-User: Biopharmaceutical Companies, Contract Research Organizations (CROs) Or Contract Development And Manufacturing Organizations (CDMOs), Research And Development Companies Subsegments: 1) By Internal Airlift Loop Bioreactor: Circulating Bioreactor, Non-Circulating Bioreactor 2) By External Airlift Loop Bioreactor: Single-Stage External Airlift Bioreactor, Multi-Stage External Airlift Bioreactor

What Is The Driver Of The Airlift Bioreactors Market?

The rising demand for biopharmaceutical products is expected to propel the growth of the airlift bioreactors market going forward. Biopharmaceutical products are medicinal products derived from living organisms or produced using biotechnological processes, including recombinant DNA technology, cell cultures, and monoclonal antibodies. The demand for biopharmaceutical products is increasing due to cell culture technologies, an increase in chronic diseases, the incidence of age-related diseases, innovations in bioprocessing, and advancements in genomics. Airlift bioreactors are highly beneficial in developing biopharmaceutical products due to their unique design and operational advantages, which are used in producing therapeutic proteins, monoclonal antibodies, and vaccines. For instance, in August 2023, according to a report by the Alliance for Regenerative Medicine, a US-based non-profit organization, there were 2,760 cell, gene, and tissue-engineering therapeutic developers worldwide in the first quarter of 2023, up 101% since 1,369 in the first quarter 2022. Therefore, rising demand for biopharmaceutical products is driving the growth of the airlift bioreactors industry.

What Is The Driver Of The Airlift Bioreactors Market?

The rising demand for biopharmaceutical products is expected to propel the growth of the airlift bioreactors market going forward. Biopharmaceutical products are medicinal products derived from living organisms or produced using biotechnological processes, including recombinant DNA technology, cell cultures, and monoclonal antibodies. The demand for biopharmaceutical products is increasing due to cell culture technologies, an increase in chronic diseases, the incidence of age-related diseases, innovations in bioprocessing, and advancements in genomics. Airlift bioreactors are highly beneficial in developing biopharmaceutical products due to their unique design and operational advantages, which are used in producing therapeutic proteins, monoclonal antibodies, and vaccines. For instance, in August 2023, according to a report by the Alliance for Regenerative Medicine, a US-based non-profit organization, there were 2,760 cell, gene, and tissue-engineering therapeutic developers worldwide in the first quarter of 2023, up 101% since 1,369 in the first quarter 2022. Therefore, rising demand for biopharmaceutical products is driving the growth of the airlift bioreactors industry.

Global Airlift Bioreactors Market Trends and Insights

Major companies operating in the airlift bioreactor market are focusing on developing advanced cloud-integrated systems to enhance process efficiency, automation, and remote monitoring. Cloud-integrated systems combine physical bioreactors with real-time remote monitoring, automated controls, and AI-driven optimization, enabling bioprocess teams to manage experiments with greater precision and speed. For instance, in April 2025, Culture Biosciences, a US-based company enabling biotech firms to develop and scale manufacturing processes in the cloud, launched Stratyx 250 featuring a mobile, cloud-integrated bioreactor design. The system offers cart-based mobility for easy relocation within labs, integrates Culture Console software for real-time remote monitoring and automation, and employs single-use bioreactor technology to reduce cleaning and downtime. Stratyx 250 also leverages artificial intelligence and machine learning to optimize bioprocesses, enabling 25% faster development timelines, 30% improved scale-up success, and a 16% lower total cost per run. Additionally, it can be used with a Cytiva 250 mL consumable that replicates large-scale reactor conditions in a smaller platform, supporting efficient process development and a faster optimization workflow.

What Are Latest Mergers And Acquisitions In The Airlift Bioreactors Market?

In September 2025, Morimatsu Group, a Japan-based engineering firm, acquired Bioengineering AG for an undisclosed amount. Through this acquisition, Morimatsu aims to enhance its airlift bioreactor capabilities by integrating Bioengineering’s established bioreactor and fermentation technologies into its global operations and expanding its advanced bioprocess equipment portfolio. Bioengineering AG is a Switzerland-based bioreactor and fermentation equipment manufacturer offering proven airlift and stirred-tank bioreactor systems for industrial and research applications.

Regional Outlook

North America was the largest region in the airlift bioreactor market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Airlift Bioreactors Market?

The airlift bioreactor market consists of sales of stainless steel and glass airlift bioreactors, bioplastics, bioactive compounds, level sensors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Airlift Bioreactors Market Report 2026?

The airlift bioreactors market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the airlift bioreactors industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.